rs369818916

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001388447.1(PABIR3):​c.328G>A​(p.Glu110Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000074 in 1,203,096 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000062 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000075 ( 0 hom. 22 hem. )

Consequence

PABIR3
NM_001388447.1 missense

Scores

1
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.66

Publications

0 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21400762).
BS2
High Hemizygotes in GnomAd4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.328G>A p.Glu110Lys missense_variant Exon 6 of 11 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.328G>A p.Glu110Lys missense_variant Exon 6 of 11 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.0000624
AC:
7
AN:
112104
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000131
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000172
AC:
3
AN:
174160
AF XY:
0.0000166
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000377
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000752
AC:
82
AN:
1090992
Hom.:
0
Cov.:
29
AF XY:
0.0000615
AC XY:
22
AN XY:
357726
show subpopulations
African (AFR)
AF:
0.0000383
AC:
1
AN:
26083
American (AMR)
AF:
0.00
AC:
0
AN:
33621
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19235
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52269
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3808
European-Non Finnish (NFE)
AF:
0.0000917
AC:
77
AN:
839616
Other (OTH)
AF:
0.0000873
AC:
4
AN:
45842
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000624
AC:
7
AN:
112104
Hom.:
0
Cov.:
23
AF XY:
0.0000875
AC XY:
3
AN XY:
34274
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30911
American (AMR)
AF:
0.00
AC:
0
AN:
10479
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3605
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2741
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6031
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000131
AC:
7
AN:
53257
Other (OTH)
AF:
0.00
AC:
0
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000567
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.0000549
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.328G>A (p.E110K) alteration is located in exon 5 (coding exon 5) of the FAM122C gene. This alteration results from a G to A substitution at nucleotide position 328, causing the glutamic acid (E) at amino acid position 110 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
14
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
.;.;T;.;.
FATHMM_MKL
Benign
0.57
D
LIST_S2
Uncertain
0.88
D;D;D;T;D
M_CAP
Pathogenic
0.36
D
MetaRNN
Benign
0.21
T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.8
.;.;L;L;.
PhyloP100
1.7
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.8
.;.;D;D;.
REVEL
Benign
0.065
Sift
Uncertain
0.0030
.;.;D;D;.
Sift4G
Uncertain
0.010
.;.;D;T;.
Polyphen
0.15
.;.;B;B;.
Vest4
0.16, 0.17
MVP
0.81
MPC
0.25
ClinPred
0.30
T
GERP RS
1.6
Varity_R
0.35
gMVP
0.45
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369818916; hg19: chrX-133979414; API